Stem cell stocks moved up on 4 January 2007 thanks to a new bill House Democrats are proposing that will expand the "types of stem cell research that can be funded by the government."
Palo Alto, CA-based StemCells Inc. (STEM) moved up
$3.11. Trading volume was
7.6 millionversus a three-month trailing average of
Ann Arbor, MI-based Aastrom Biosciences Inc. (ASTM) moved up
$1.39. Tradiing volume was
5.75 millionversus a three-month trailing average of
To date, President George W. Bush has vetoed only one bill put forth by Congress and it was related to stem cell research. Bush will probably veto a second stem cell bill, but this time the "100-member Senate is believed to have enough support to overturn his veto with a two-thirds majority vote, though the 435-member House would have a more difficult time getting the necessary votes."
The House of Representatives passed a embryonic stem cell related bill with a "
253-174 vote-- short of the two-thirds margin needed to overturn a presidential veto." The bill now goes to the Senate.
Stem cells stocks, which spiked upward prior to the vote, fell after the vote.1/12/2007 1/8/2007 symbol close ------change------ ---volume---- close =================================================================== STEM $3.04 down $0.32 (9.25%) 5.8M vs. 2.7M $3.52 ASTM $1.37 down $0.09 (6.16%) 3.9M vs. 2.6M $1.58
Creator: Gerald D. Thurman
Created: 05 January 2007